Michael Soeberdt (M Soeberdt)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Neoadjuvant Chemotherapy

Atopic Dermatitis

Top Venues

Experimental dermatology

The British journal of dermatology

Journal of medicinal chemistry

The Journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Kinga Fanni Tóth, Dorottya Ádám, József Arany, Yesid A Ramirez, Tamás Bíró, Jennifer I Drake, Alison O'Mahony, Attila Gábor Szöllősi, Szilard Poliska, Ana Kilić, Michael Soeberdt, Christoph Abels, Attila Oláh
Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release. Experimental dermatology 33 (1) (2024)
Christoph Abels, Michael Soeberdt, A Kilic, H Reich, U Knie, C Jourdan, K Schramm, S Heimstaedt-Muskett, Clarissa Masur, Rolf-Markus Szeimies
A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. The British journal of dermatology 185 (2) (2021)
Rosanna Marsella, Kim Ahrens, Rachel Wilkes, Michael Soeberdt, Christoph Abels
Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis. Experimental dermatology (2021)
Ehrhardt Proksch, Michael Soeberdt, Claudia Neumann, Ana Kilic, Christoph Abels
Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model. Experimental dermatology 28 (9) (2020)
Jeremy Chéret, Jennifer Gherardini, Michael Soeberdt, Jennifer E Hundt, Christoph Abels, Marta Bertolini, Ralf Paus
Non-neuronal kappa-opioid receptor activation enhances epidermal keratinocyte proliferation, and modulates mast cell functions in human skin ex vivo. The Journal of dermatology 47 (8) (2020)
Michael Soeberdt, Ana Kilic, Christoph Abels
Current and emerging treatments targeting the neuroendocrine system for disorders of the skin and its appendages. Experimental dermatology 29 (9) (2020)
C Masur, Michael Soeberdt, A Kilic, U Knie, Christoph Abels
Safety and efficacy of topical formulations containing 0·5, 1 and 2% glycopyrronium bromide in patients with primary axillary hyperhidrosis: a randomized, double-blind, placebo-controlled study. The British journal of dermatology 182 (1) (2019)
Christoph Abels, Michael Soeberdt
Can we teach old drugs new tricks?-Repurposing of neuropharmacological drugs for inflammatory skin diseases. Experimental dermatology 28 (9) (2019)
Michael Soeberdt, Peter Molenveld, Roy P M Storcken, Renaud Bouzanne des Mazery, Geert Jan Sterk, Reshma Autar, Marjon G Bolster, Clemens Wagner, Sebastianus N H Aerts, Frank R van Holst, Anita Wegert, Giovanni Tangherlini, Bastian Frehland, Dirk Schepmann, Dieter Metze, Tobias Lotts, Ulrich Knie, Kun-Yuan Lin, Tai-Yu Huang, Chih-Ching Lai, Sonja Ständer, Bernhard Wünsch, Christoph Abels
Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo. Journal of medicinal chemistry 60 (6) (2017)